Audible. Only £0.99 a month for the first 3 months + £10 Audible voucher. Pay £0.99 for the first 3 months, and £7.99/month thereafter. Renews automatically. Start my membership.

Ticagrelor or Dual Therapy After Stents: Key Insights from the ULTIMATE-DAPT Study
Nov 24 2024
Length: 11 mins
Podcast

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to basket failed.

Please try again later

Add to wishlist failed.

Please try again later

Remove from wishlist failed.

Please try again later

Adding to library failed

Please try again

Follow podcast failed

Unfollow podcast failed

Ticagrelor or Dual Therapy After Stents: Key Insights from the ULTIMATE-DAPT Study

Listen for free

View show details

Summary
In this episode, we take an in-depth look at the groundbreaking ULTIMATE-DAPT clinical trial, which examines the safety and efficacy of using ticagrelor alone compared to combining it with aspirin for patients who have undergone stent placement after acute coronary syndromes. We’ll break down the study’s methodology, key findings, and their potential to reshape post-PCI treatment strategies by reducing bleeding risks while maintaining cardiovascular protection. Join us for a clear and insightful discussion on how this research could change the way heart patients are cared for worldwide. A must-listen for anyone interested in the latest advances in cardiology and patient-centered care.

Show More Show Less

Show More Show Less

What listeners say about Ticagrelor or Dual Therapy After Stents: Key Insights from the ULTIMATE-DAPT Study

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews

No Reviews are Available

Report a review on Amazon